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INFLUENCE OF THE NO/L-ARGININE-SYSTEM ON
TACROLIMUS-INDUCED CHANGES OF RENAL
HEMODYNAMICS
E. Heidbreder, Daniela Kleinert, K. Lopau. 1University Hospital
Wuerzburg, , Germany
Nitric oxide (NO) is involved in the regulation of renal hemodynamics in
various pathophysiological conditions. Tacrolimus (Tac) is known for its
nephrotoxic side effects which are believed to be partly due to acute
vasoconstriction in the renal microvasculature. We examined if L-Argi-
nine (Arg)-derived NO could improve renal microcirculatory changes in
rat kidneys after acute renal failure due to clamping of both renal arteries
for 40 min and infusion of Tac, Arg and L-monomethylarginine (MeArg)
as unspecific antagonist of NO-synthases. We determined GFR, RPF, FF,
MAP as functional parameters in 4 groups of 8 animals each during and
after infusion of saline (Contr), Tac (0,05 mg / kg x h), Tac 1 Arg (500
mg / kg x h) and Tac 1 MeArg (1 mg / kg x h) for 120 min.. Clamping
induced a significant fall in GFR during the whole experimental proce-
dure from 1,37 ml/min to 0,08 ml/min in Contr. Tac even worsened the
observed changes (1,39 ml/min3 0,038 ml/min), whereas simultaneous
infusion of Arg with Tac improved GFR to 0,190 ml/min.. MeArg-
coadministration showed non-significant changes compared to Tac. RPF
fell in all groups (Contr 5,50 3 0,19 ml/min, Tac 6,56 3 0,04 ml/min;
Tac 1 Arg 6,66 3 0,82 ml/min*; Tac 1 MeArg 6,11 3 0,19 ml/min).
Filtration fraction rose in Contr, Tac and Tac1MeArg significantly
higher than in Arg (86%, 94%, 72% and 59% respectively) indicating
vasoconstriction of the efferent arteriole. During the infusion period we
found no significant differences of MAP between the four groups. Ad-
ministration of Tac leads to further deterioration of renal function after
induction of acute ischemic renal failure. The NO-donator L-arginine
could significantly alleviate the described changes most likely due to
activation of NOS and consecutive endothelium-dependent vasorelax-
ation.
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MYOCARDIAL ENDOTHELIN-1 EXPRESSION
FOLLOWING HEART TRANSPLANTATION
Claudio Ferri, Giuliana Properzi, Gianluca Tomassoni, Anna
Santucci, James Young, Randall Starling, Norman Ratliff, Murat
Tuzcu, Patrick McCarthy, Mohamad Yamani. 1Department of Internal
Medicine and Public Health, University of l’Aquila, l’Aquila, Italy,
2Departments of Cardiology, Pathology, Cardiothoracic Surgery,
Cleveland Clinic Foundation, Cleveland, OH, United States
Endothelin-1 (ET-1), a potent vasoconstrictor, is released in response to
several inflammatory cytokines following heart transplantation. In order
to investigate the role of myocardial ET-1 expression (quantified by
immunohistochemistry as weakly positive, 11, 12, 13 and 14) in
cardiac allograft rejection (graded from 0 to 4 according to the Interna-
tional Society Heart Lung Transplantation criteria), myocardial fibrosis
and subsequent coronary vasculopathy, endomyocardial biopsies were
evaluated at 3 months post transplant in 31 heart transplant recipients.
The 3-month interval was chosen because most of the episodes of
rejection occur during this period. Transplant coronary vasculopathy was
documented by cardiac catheterization at 1 year of follow up. Resulting
data showed that vascular ET-1 expression was increased in the 3/31
patients experiencing acute cellular rejection from grade 2 (aggressive
lymphocytic infiltration) to grade 3A (multifocal aggressive infiltrate).
Interestingly, two patients had CMV viremia and hepatitis C at the time
of biopsy and also showed positive vascular ET-1 in the absence of
rejection. Interstitial ET-1 expression was positive in 18 and negative in
13 patients. The two groups had similar baseline characteristics (age,
diabetes, hypertension, hyperlipidemia) and were on similar immunosup-
pressant medications. Positive interstitial ET-1 was significantly associ-
ated with the presence of post transplant myocardial fibrosis (12/18 vs
1/13, p50.001), and increased incidence of coronary vasculopathy at 1
year of follow up (70.5% vs 7.7%, p50.001). However, the average
number of episodes of rejection (grade 2 and grade 3A) during the first
3 months of transplant was significantly reduced in the interstitial ET-1
positive patients (1.0060.68 vs 1.8461.77 episodes per patient,
p50.03). In conclusion, our study showed an evident association be-
tween acute rejection and vascular ET-1 expression. Further, it also
demonstrated that interstitial ET-1 expression was present in patients
manifesting post transplant myocardial fibrosis at 3 months and coronary
vasculopathy at 1 year of follow up. Interestingly, positive interstitial
ET-1 and fibrosis were also associated with a significantly lower inci-
dence of rejection. Thus, interstitial ET-1 expression seems to play a
significant role in the development of both myocardial fibrosis and
coronary vasculopathy in heart transplant recipients, and thereby strongly
influences post transplant prognosis. The low rate of rejection in patients
with positive interstitial ET-1 expression and myocardial fibrosis is
extremely interesting and merits further investigations.
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BLUNTED VASODILATORY RESPONSES IN THE
CUTANEOUS MICROCIRCULATION OF CIGARETTE
SMOKERS
Cyril Pellaton, Sandrine Kubli, Francois Feihl, Bernard Waeber.
1University Hospital, Division of Pathophysiology, Lausanne,
Switzerland
Background : To assess the vasodilatory response to acetylcholine (Ach,
endothelium-dependent vasodilator) and Na nitroprusside (SNP, endo-
thelium-independent vasodilator) in the skin microcirculation of habitual
cigarette smokers.
Methods : Male healthy habitual smokers taking no medication acting
on the cardiovascular system were included. They were divided in
younger (Group 1, n 5 10, age : 18 to 35 years; mean 5 7 pack-years)
and older (Group 2, n 5 10, age : 40 to 60 years; mean 530 pack-years).
Younger (Group 3, n 5 10) and older controls (Group 4, n 5 10)
consisted of age-matched non-smokers. On the day of the experiment the
subjects of Groups 1 and 2 were asked to smoke at least 15 cigarettes
starting in the morning. At 4 p.m. they had to smoke within 5 min a filter
cigarette containing 1 mg nicotine. Subjects of Groups 3 and 4 had a
sham-smoking session at 4 p.m. Ach, 1%, and SNP, 0.1%, were admin-
istered transcutaneously for 7 min on the volar face of the right forearm
using iontophoresis. This was done 15 min and 40 min after the end of
the smoking session for Ach and SNP, respectively. The skin blood flow
responses were evaluated using a laser-Doppler flowmeter allowing to
scan the surface of Ach and SNP application (circular area, 1 cm
diameter) .
Results : The following Table shows the peak changes induced by Ach
and SNP (perfusion units, means6SD):
Younger Older
Ach SNP Ach SNP
Non-smokers 505665 425699 473691 392671
Smokers 4666102 416659 302650** 3016104*
*p,0.05;**p,0.01, Smokers versus Non-smokers
Conclusion : These data show that the vasodilatory response of the
skin microvasculature is impaired in subjects having smoked cigarettes
for many years. This abnormality involves both the Ach and the SNP
responses, which implies a diminished relaxant capacity of vascular
smooth muscle cells, even if an underlying endothelial dysfunction
cannot be ruled out.
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